鲁抗医药：9月19日召开董事会会议

Company Overview - Lu Kang Pharmaceutical (SH 600789) announced a temporary board meeting on September 19, 2025, to review the mid-term adjustments to the 2025 investment plan [1] - As of the report, Lu Kang Pharmaceutical has a market capitalization of 8.9 billion yuan [1] Revenue Composition - For the year 2024, the revenue composition of Lu Kang Pharmaceutical is as follows: - Human antibiotics account for 54.29% - Veterinary antibiotics account for 39.72% - Other businesses account for 4.89% - Additional business activities account for 1.1% [1]